STSelina M. Tucker

Selina M. Tucker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Selina M. Tucker has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Endothelial Dysfunction in Preeclampsia: Focus on the Uteroplacental Circulation

    by Selina M. Tucker, Nataliia Hula, Jennifer J. Gardner, Styliani Goulopoulou

    Preeclampsia is a pregnancy disorder characterized by de novo maternal hypertension, end-organ damage, and fetal complications. It is also associated with increased long-term cardiovascular risk for both the mother and offspring. A general lack of understanding of this disease prevents effective treatment and prevention, with delivery of the fetoplacental unit being the current standard of care for severe cases. A hallmark characteristic of the maternal syndrome is endothelial dysfunction in both reproductive and nonreproductive vascular beds. As the uterine vascular bed serves as the interface between the maternal and fetal circulation, it is pivotal in the cardiovascular function of both mother and fetus. In this review, we highlight uterine artery endothelial maladaptation as a central feature of preeclampsia and discuss its anatomic, cellular, and circulating correlates.


  • Open Access

    Impairment of local metabolic coronary control involves perfusion-contraction matching not supply–demand imbalance

    by Salman I. Essajee, Gregory M. Dick, Selina M. Tucker, Cooper M. Warne, C. Alberto Figueroa, Daniel A. Beard, Dirk J. Duncker, Johnathan D. Tune

    Understanding of local metabolic control of coronary flow remains stifled by debate around data interpretation and anticipated outcomes. To address this question we performed experiments in a cannulated coronary preparation in swine to precisely control flow as myocardial oxygen consumption (MVO2) and contractile function were modulated by dobutamine (1–10 μg/kg/min, iv), reductions in coronary perfusion pressure (CPP), and the inhibition of voltage-gated K+ channels with 4-aminopyridine (4-AP; 1 mM, ic). Reduction of CPP to 40 mmHg diminished coronary flow (~ 55%; P < 0.001) and systolic wall thickening (~ 35%; P < 0.001). 4-AP-mediated reductions in coronary flow (~ 35%; P = 0.01) and wall thickening (~ 40%; P < 0.05) were restored by returning coronary flow to normal baseline levels. Dobutamine increased heart rate and coronary flow ~ 65% (P < 0.001) and coronary flow remained tightly coupled with MVO2. Inhibition of coronary responses to dobutamine was associated with an ~ 35% reduction in wall thickening and an ~ 50% increase in MVO2. Reductions in CPP, administration of 4-AP, and diminished flow during dobutamine infusion were associated with proportional decreases in coronary flow and MVO2. Wall thickening progressively decreased as coronary flow was reduced below ~ 5.0–7.5 μL/g/beat regardless of whether the decrease was due to diminished “supply” (CPP, 4-AP) or limitations during increased “demand” (flow clamp or restriction with dobutamine). These findings demonstrate that impairments in local metabolic control of coronary flow are reliably demonstrated by decreases in contractile function as a consequence of reductions in the volume of myocardial perfusion per beat.


  • Gestational chronic intermittent hypoxia triggers maternal inflammation and disrupts placental stress responses

    by Jennifer J. Gardner, Reneé de Nazaré Oliveira da Silva, Jessica L. Bradshaw, Steve Mabry, E. Nicole Wilson, Nataliia Hula, Selina M. Tucker, Isabelle K. Gorham, Desirae Escalera, Leslie Lopez, et al.

    Late-gestation exposure to even mild, short-term, chronic intermittent hypoxia (CIH) is sufficient to initiate maternal inflammation and disrupt key placental stress response mechanisms, despite occurring after placental development is largely complete. These findings highlight a novel temporal maternal and placental vulnerability in late pregnancy and identify novel targets for understanding the pathophysiology of hypoxia-related pregnancy complications.


  • Potassium as an electro-metabolic signal for local coronary vasodilation

    by Johnathan D. Tune, Dirk J. Duncker, Adam G. Goodwill, Cooper M. Warne, Salman I. Essajee, Selina M. Tucker, Steven A. Romero, Shawn B. Bender, Daniel A. Beard, C. Alberto Figueroa, et al.

    This study tested the hypothesis that K+ serves as an in vivo signal coupling coronary blood flow with the oxidative requirements of the myocardium. Experiments were performed in swine in which coronary parameters and arterial and coronary venous [K+] were measured under baseline conditions, during exogenous administration of K+ (1–5 mM; n = 4), during increases in myocardial oxygen consumption (MVO2) to dobutamine (n = 7) and exercise (n = 6), alterations in coronary perfusion pressure (CPP; n = 8), and systemic hypoxemia (PaO2 to ~ 30 mmHg; n = 7). Exogenous intracoronary K+ increased blood flow (~ 20%) in direct proportion to the coronary venous [K+] up to the lethal limit of ~ 10 mM. Dobutamine increased coronary flow and MVO2 ~ threefold but the coronary venous–arterial [K+] gradient (i.e., a surrogate index of myocardial release of K+ into the coronary circulation) did not change. Similarly, exercise increased coronary flow and MVO2 ~ 2.5-fold without a change in the coronary venous–arterial [K+] gradient. The coronary venous–arterial [K+] gradient did not change over the CPP range of 140–40 mmHg. Hypoxemia increased coronary blood flow ~ twofold and coronary vascular resistance was weakly associated with < 0.5 mM change in the coronary venous–arterial [K+] gradient. Intracoronary glibenclamide dose-dependently (1–3 mg/min; n = 4) increased coronary resistance but did not affect the coronary venous–arterial [K+] gradient. Intracoronary pinacidil dose-dependently (0.3–3.0 µg/kg/min; n = 3) increased coronary blood flow but did not affect the coronary venous–arterial [K+] gradient. Similarly, intravenous glibenclamide (3 mg/kg; n = 6) increased coronary resistance but did not affect the coronary venous–arterial [K+] gradient in exercising swine. These findings fail to support the concept that myocardial interstitial [K+] couples coronary blood flow to MVO2 during physiologic increases in cardiac work or when oxygen delivery is constrained.


  • Open Access

    Gestational Chronic Intermittent Hypoxia Triggers Maternal Inflammation and Disrupts Placental Stress Responses

    by Jennifer Jordan Gardner, Reneé de Nazaré Oliveira da Silva, Jessica L. Bradshaw, Steve Mabry, Elizabeth Nicole Wilson, Nataliia Hula, Selina M. Tucker, Isabelle K. Gorham, Desirae Escalera, Leslie Lopez, et al.

    Gestational hypoxia is associated with placental cellular responses, including oxidative stress and inflammation. Circulating cell-free mitochondrial DNA (ccf-mtDNA) is a marker of cell stress, that can be transported within extracellular vehicles (EVs), eliciting proinflammatory responses. We hypothesized that systemic exposure to chronic intermittent hypoxia (CIH) during late pregnancy would increase maternal inflammation, alter circulating EV characteristics, and disrupt placental stress responses. Pregnant rats were exposed to CIH (n=8) or normoxia (n=9) during gestational days 15-20 (term 22-23 days). On GD20, ccf-mtDNA and EV-associated mtDNA (EV-mtDNA) were quantified with qRT-qPCR, while maternal circulating cytokines were quantified using a MILLIPLEX® cytokine array. Systemic oxidative stress was measured by plasma advanced oxidation protein products (AOPP). Placental stress responses were evaluated by examining the balance between proinflammatory and antioxidant gene expression and the activation of proteins involved in apoptotic and autophagic processes. CIH exposure increased placental weights (p=0.015) and reduced placental efficiency (p=0.0006) without affecting fetal biometrics (p>0.05). Absolute ccf-mtDNA and EV-mtDNA content were unchanged (p>0.05), but EV concentrations were reduced (p=0.011) in response to CIH, suggesting an increase in EV-mtDNA per EV. Maternal interleukin-18 (IL-18) concentrations increased in the CIH group (p=0.047). Placental mRNA expression of catalase (p=0.048) and sod2 (p=0.038) were upregulated, while autophagy-related proteins Beclin-1 (p=0.006) and p62 (p=0.023) were also increased in response to CIH, with no changes in LC3A/B expression (p>0.05). Gestational CIH disrupts maternal EV and inflammatory profiles, reduces placental efficiency, and modulates placental antioxidant and autophagic mechanisms, without impairing fetal growth in rats.


  • Open Access

    Pregnancy-induced oxidative stress and inflammation are not associated with impaired maternal neuronal activity or memory function

    by Jessica L. Bradshaw, E. Nicole Wilson, Jennifer J. Gardner, Steve Mabry, Selina M. Tucker, Nataliya Rybalchenko, Edward Vera, Styliani Goulopoulou, Rebecca L. Cunningham

    Healthy pregnancy is associated with elevated maternal systemic and brain oxidative stress. During postpregnancy, brain oxidative stress remains elevated whereas systemic oxidative stress is resolved. This sustained maternal brain oxidative stress is associated with learning impairments and decreased anxiety-like behavior during the postpregnancy period.


  • Open Access

    Oxidative stress induces release of mitochondrial DNA into the extracellular space in human placental villous trophoblast BeWo cells

    by Jennifer J. Gardner, Spencer C. Cushen, Reneé de Nazaré Oliveira da Silva, Jessica L. Bradshaw, Nataliia Hula, Isabelle K. Gorham, Selina M. Tucker, Zhengyang Zhou, Rebecca L. Cunningham, Nicole R. Phillips, et al.

    This is the first study to test whether trophoblast cells release mitochondrial (mt)DNA in response to oxidative stress and to identify mechanisms of release and biological forms of mtDNA from this cellular type. This research identifies potential cellular mechanisms that can be used in future investigations to establish the source and biomarker potential of circulating mtDNA in preclinical experimental models and humans.


  • Open Access

    Oxidative stress induces release of mitochondrial DNA into the extracellular space in human placental villous trophoblast BeWo cells

    by Jennifer J. Gardner, Spencer C. Cushen, Reneé de Nazaré Oliveira da Silva, Jessica L. Bradshaw, Nataliia Hula, Isabelle K. Gorham, Selina M. Tucker, Zhengyang Zhou, Rebecca L. Cunningham, Nicole R. Phillips, et al.

    Circulating cell-free mitochondrial DNA (ccf-mtDNA) is an indicator of cell death, inflammation, and oxidative stress. ccf-mtDNA differs in pregnancies with placental dysfunction from healthy pregnancies and the direction of this difference depends on gestational age and method of mtDNA quantification. Reactive oxygen species (ROS) trigger release of mtDNA from non-placental cells; yet it is unknown whether trophoblast cells release mtDNA in response to oxidative stress, a common feature of pregnancies with placental pathology. We hypothesized that oxidative stress would induce cell death and release of mtDNA from trophoblast cells. BeWo cells were treated with antimycin A (10-320 μM) or rotenone (0.2-50 μM) to induce oxidative stress. A multiplex real-time quantitative PCR (qPCR) assay was used to quantify mtDNA and nuclear DNA in membrane bound, non-membrane bound, and vesicular-bound forms in cell culture supernatants and cell lysates. Treatment with antimycin A increased ROS (pin vitro model of human trophoblast cells. Intersection between autophagy and necrosis may mediate the release of mtDNA from the placenta in pregnancies exposed to oxidative stress. NEW & NOTEWORTHY: This is the first study to test whether trophoblast cells release mitochondrial DNA in response to oxidative stress and to identify mechanisms of release and biological forms of mtDNA from this cellular type. This research identifies potential cellular mechanisms that can be used in future investigations to establish the source and biomarker potential of circulating mitochondrial DNA in preclinical experimental models and humans.